Search Results

• • 21 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Implications of false?positive results for future cancer screenings

  Authors:Glen B. Taksler, Nancy L. Keating, and Michael B. RothbergFrom:Cancer (Vol. 124, Issue 11) Peer-Reviewed

  June 1, 2018 Report

   Citation Only

• Barriers to accessing palliative care for pediatric patients with cancer: A review of the literature

  Authors:Emily R. Haines, A. Corey Frost, Heather L. Kane, and Franziska S. RokoskeFrom:Cancer (Vol. 124, Issue 11) Peer-Reviewed

  June 1, 2018 Report

   Citation Only

• Development of CNS metastases and survival in patients with inflammatory breast cancer

  Authors:Marc I. Uemura, John T. French, Kenneth R. Hess, Diane Liu, Kanwal Raghav, Gabriel N. Hortobagyi, et al.From:Cancer (Vol. 124, Issue 11) Peer-Reviewed

  June 1, 2018 Report

   Citation Only

• A phase 2 study of the PARP inhibitor veliparib plus temozolomide in patients with heavily pretreated metastatic colorectal cancer

  Authors:Michael J. Pishvaian, Rebecca S. Slack, Wei Jiang, A. Ruth He, Jimmy J. Hwang, Amy Hankin, et al.From:Cancer (Vol. 124, Issue 11) Peer-Reviewed

  June 1, 2018 Report

   Citation Only

• Disparities in the survivorship experience among Latina survivors of breast cancer

  Authors:Tinuke O. Olagunju, Yihang Liu, Li?Jung Liang, James M. Stomber, Jennifer J. Griggs, Patricia A. Ganz, et al.From:Cancer (Vol. 124, Issue 11) Peer-Reviewed

  June 1, 2018 Report

   Citation Only

• Long-term safety and survival with gefitinib in select patients with advanced non-small cell lung cancer: Results from the US IRESSA Clinical Access Program (ICAP)

  Authors:Fred R. Hirsch, Lecia V. Sequist, Ira Gore, Meghan Mooradian, George Simon, Elisabeth F. Croft, et al.From:Cancer (Vol. 124, Issue 11) Peer-Reviewed

  June 1, 2018 Report

   Citation Only

• Screening for emotional disorders in patients with cancer using the Brief Symptom Inventory (BSI) and the BSI-18 versus a standardized psychiatric interview (the World Health Organization Composite International Diagnostic Interview)

  Authors:Luigi Grassi, Rosangela Caruso, Alex J. Mitchell, Silvana Sabato, and Maria Giulia NanniFrom:Cancer (Vol. 124, Issue 11) Peer-Reviewed

  June 1, 2018 Report

   Citation Only

• Improving therapy for patients with epidermal growth factor receptor-mutant lung cancer

  Authors:Kathryn C. Arbour and Gregory J. RielyFrom:Cancer (Vol. 124, Issue 11) Peer-Reviewed

  June 1, 2018 Report

   Citation Only

• Beyond symptomatic relief for chemotherapy-induced peripheral neuropathy: Targeting the source

  Authors:Jiacheng Ma, Annemieke Kavelaars, Patrick M. Dougherty, and Cobi J. HeijnenFrom:Cancer (Vol. 124, Issue 11) Peer-Reviewed

  June 1, 2018 Report

   Citation Only

• Where there is smoke, there is not always fire

  Authors:David C. Johnson and Joann G. ElmoreFrom:Cancer (Vol. 124, Issue 11) Peer-Reviewed

  June 1, 2018 Report

   Citation Only

• Treatment-emergent hypertension and efficacy in the phase 3 Study of (E7080) lenvatinib in differentiated cancer of the thyroid (SELECT)

  Authors:Lori J. Wirth, Makoto Tahara, Bruce Robinson, Sanjeev Francis, Marcia S. Brose, Mouhammed Amir Habra, et al.From:Cancer (Vol. 124, Issue 11) Peer-Reviewed

  June 1, 2018 Report

   Citation Only

• Impact of the posttransplant lymphoproliferative disorder subtype on survival

  Authors:Jean L. Koff, Jing?Xia Li, Xinyan Zhang, Jeffrey M. Switchenko, Christopher R. Flowers, and Edmund K. WallerFrom:Cancer (Vol. 124, Issue 11) Peer-Reviewed

  June 1, 2018 Report

   Citation Only

• Long-term outcome of relapsed acute promyelocytic leukemia treated with oral arsenic trioxide-based reinduction and maintenance regimens: A 15-year prospective study

  Authors:Harinder Gill, Rita Yim, Harold K. K. Lee, Vivien Mak, Shek?Ying Lin, Bonnie Kho, et al.From:Cancer (Vol. 124, Issue 11) Peer-Reviewed

  June 1, 2018 Report

   Citation Only

• Complex karyotype in patients with mantle cell lymphoma predicts inferior survival and poor response to intensive induction therapy

  Authors:I. Brian Greenwell, Ashley D. Staton, Michael J. Lee, Jeffrey M. Switchenko, Debra F. Saxe, Joseph J. Maly, et al.From:Cancer (Vol. 124, Issue 11) Peer-Reviewed

  June 1, 2018 Report

   Citation Only

• Salvage treatment using carbon ion radiation in patients with locoregionally recurrent nasopharyngeal carcinoma: Initial results

  Authors:Jiyi Hu, Cihang Bao, Jing Gao, Xiyin Guan, Weixu Hu, Jing Yang, et al.From:Cancer (Vol. 124, Issue 11) Peer-Reviewed

  June 1, 2018 Report

   Citation Only

• Complex epidermal growth factor receptor mutations and their responses to tyrosine kinase inhibitors in previously untreated advanced lung adenocarcinomas

  Authors:Bo Zhang, Shuyuan Wang, Jie Qian, Wenjia Yang, Fangfei Qian, Jun Lu, et al.From:Cancer (Vol. 124, Issue 11) Peer-Reviewed

  June 1, 2018 Report

   Citation Only

• Mature results of a prospective study of deintensified chemoradiotherapy for low-risk human papillomavirus-associated oropharyngeal squamous cell carcinoma

  Authors:Bhishamjit S. Chera, Robert J. Amdur, Joel E. Tepper, Xianming Tan, Jared Weiss, Juneko E. Grilley-Olson, et al.From:Cancer (Vol. 124, Issue 11) Peer-Reviewed

  June 1, 2018 Report

   Citation Only

• Pilot study of a multimodal intervention to enhance sexual function in survivors of hematopoietic stem cell transplantation

  Authors:Areej El?Jawahri, Sarah R. Fishman, Julie Vanderklish, Don S. Dizon, Nicole Pensak, Lara Traeger, et al.From:Cancer (Vol. 124, Issue 11) Peer-Reviewed

  June 1, 2018 Report

   Citation Only

• Perceptions of risk of infertility among male survivors of childhood cancer: A report from the Childhood Cancer Survivor Study

  Authors:Jordan Gilleland Marchak, Kristy D. Seidel, Ann C. Mertens, Chad W.M. Ritenour, Karen Wasilewski?Masker, Wendy M. Leisenring, et al.From:Cancer (Vol. 124, Issue 11) Peer-Reviewed

  June 1, 2018 Report

   Citation Only

• Erlotinib plus either pazopanib or placebo in patients with previously treated advanced non-small cell lung cancer: A randomized, placebo-controlled phase 2 trial with correlated serum proteomic signatures

  Authors:David R. Spigel, Howard A. Burris, F. Anthony Greco, Kent C. Shih, Victor G. Gian, Andrew J. Lipman, et al.From:Cancer (Vol. 124, Issue 11) Peer-Reviewed

  June 1, 2018 Report

   Citation Only